Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have earned an average rating of “Moderate Buy” from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $131.00.
ADUS has been the topic of a number of research reports. Weiss Ratings downgraded Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Barclays dropped their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a report on Friday, May 15th.
View Our Latest Research Report on Addus HomeCare
Institutional Investors Weigh In On Addus HomeCare
Addus HomeCare Stock Up 0.3%
Shares of NASDAQ:ADUS opened at $93.28 on Wednesday. The stock’s 50-day moving average price is $93.73 and its two-hundred day moving average price is $103.31. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare has a 12-month low of $87.95 and a 12-month high of $124.43. The firm has a market cap of $1.74 billion, a price-to-earnings ratio of 17.24, a PEG ratio of 1.28 and a beta of 0.89.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. The firm had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the company earned $1.42 EPS. On average, research analysts forecast that Addus HomeCare will post 6.24 EPS for the current year.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
